Clinical Trial Update: Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of androgen receptor–directed therapies (darolutamide or enzalutamide) on cognitive function in prostate cancer pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Hormone-sensitive Prostate Cancer
• Non-metastatic Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Darolutamide (darolutamide)
• Enzalutamide (enzalutamide)

Snippet

Sponsor: Alliance Foundation Trials, LLC. | Conditions: Metastatic Prostate Cancer, Prostate Cancer Metastatic | Phase 2 | Status: ACTIVE_NOT_RECRUITING